Outset Medical, Inc. (OM)
Nasdaq · Electromedical & Electrotherapeutic Apparatus · Manufacturing · CIK 1484612 · fiscal year ends in Dec
Closing price $4.04 on 30 Oct 2026; 52-week range $2.96 to $13.12.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $117.8M
- Revenue growth
- -1.3%
- Net income, last twelve months
- -$74.3M
- Earnings per share
- -$4.09
- Gross margin
- 41.8%
- Operating margin
- -56.1%
- Net margin
- -63.1%
- Free cash flow
- -$38.9M
- Return on equity
- -77.1%
- Market value
- $75.9M
- Cash
- $35.0M
- Debt
- $97.6M
- Debt to equity
- 1.01
- Shares outstanding
- 18.8M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $119.5M | -$66.7M | -$81.7M | -$5.37 | -$47.1M | 10-K filed 13 Feb 2026 |
| FY2024 | 31 Dec 2024 | $113.7M | -$113.4M | -$128.0M | -$36.90 | -$117.2M | 10-K filed 28 Feb 2025 |
| FY2023 | 31 Dec 2023 | $130.4M | -$169.8M | -$172.8M | -$52.20 | -$134.8M | 10-K filed 21 Feb 2024 |
| FY2022 | 31 Dec 2022 | $115.4M | -$161.0M | -$163.0M | -$50.70 | -$154.1M | 10-K filed 13 Feb 2023 |
| FY2021 | 31 Dec 2021 | $102.6M | -$130.5M | -$131.9M | -$43.35 | -$133.4M | 10-K filed 23 Feb 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $31.6M | -$18.0M | -$0.97 |
| Q1 FY2026 | 31 Mar 2026 | $27.9M | -$19.0M | -$1.03 |
| Q4 FY2025 | 31 Dec 2025 | $28.9M | -$19.5M | -$1.09 |
| Q3 FY2025 | 30 Sep 2025 | $29.4M | -$17.8M | -$1.00 |
| Q2 FY2025 | 30 Jun 2025 | $31.4M | -$18.5M | -$1.04 |
| Q1 FY2025 | 31 Mar 2025 | $29.8M | -$25.8M | -$3.66 |
| Q4 FY2024 | 31 Dec 2024 | $29.5M | -$25.6M | -$7.35 |
| Q3 FY2024 | 30 Sep 2024 | $28.7M | -$27.9M | -$8.25 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By product, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Consumables Product | $54.1M | 45.3% |
| Service and Other Revenue | $34.7M | 29.0% |
| Consoles Product | $30.7M | 25.7% |
Company events
The newest 8-K filings of 66 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 28 Aug 2026 | 8-K | Leadership change | 5.02 |
| 6 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 17 Jun 2026 | 8-K | Results, Material agreement | 1.01, 2.02, 9.01 |
| 5 Jun 2026 | 8-K | Shareholder vote | 5.07 |
| 29 May 2026 | 8-K | Leadership change | 5.02 |
| 7 May 2026 | 8-K | Results | 2.02, 9.01 |
| 11 Feb 2026 | 8-K | Results | 2.02, 9.01 |
| 27 Jan 2026 | 8-K | Other events | 8.01, 9.01 |
| 12 Jan 2026 | 8-K | Results, Leadership change, Investor update | 2.02, 5.02, 7.01, 9.01 |
| 10 Nov 2025 | 8-K | Results | 2.02, 9.01 |
| 6 Aug 2025 | 8-K | Results | 2.02, 9.01 |
| 3 Jun 2025 | 8-K | Leadership change, Shareholder vote, Investor update | 5.02, 5.07, 7.01, 9.01 |
Every filing
The newest filings with the SEC of 164 held.
| Filed | Form | Period |
|---|---|---|
| 28 Aug 2026 | 8-K | 27 Aug 2026 |
| 6 Aug 2026 | 10-Q | 30 Jun 2026 |
| 6 Aug 2026 | 8-K | 6 Aug 2026 |
| 17 Jun 2026 | 8-K | 14 Jun 2026 |
| 5 Jun 2026 | 8-K | 4 Jun 2026 |
| 29 May 2026 | 8-K | 26 May 2026 |
| 29 May 2026 | SD | – |
| 7 May 2026 | 10-Q | 31 Mar 2026 |
| 7 May 2026 | 8-K | 7 May 2026 |
| 24 Apr 2026 | DEFA14A | – |
| 24 Apr 2026 | DEF 14A | 4 Jun 2026 |
| 13 Feb 2026 | S-8 | – |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 2 Oct 2026 | Leonard Braden Michael, 10% owner | Purchase | 16,575 | $3.88 | $64.2K | 2,764,610 | 5 Oct 2026 |
| 1 Oct 2026 | Leonard Braden Michael, 10% owner | Purchase | 228,334 | $3.53 | $806.0K | 2,748,035 | 5 Oct 2026 |
| 17 Aug 2026 | Trigg Leslie, Chair and CEO | Sale outside a trading plan | 3,437 | $4.39 | $15.1K | 194,597 | 18 Aug 2026 |
| 17 Aug 2026 | Brottem John L., General Counsel | Sale outside a trading plan | 2,632 | $4.39 | $11.6K | 87,475 | 18 Aug 2026 |
| 17 Aug 2026 | Gaeta Renee, Chief Financial Officer | Sale outside a trading plan | 4,543 | $4.39 | $19.9K | 180,840 | 18 Aug 2026 |
| 3 Jun 2026 | Gaeta Renee, Chief Financial Officer | Sale outside a trading plan | 17,672 | $4.94 | $87.3K | 113,753 | 5 Jun 2026 |
| 15 May 2026 | Trigg Leslie, Chair and CEO | Sale outside a trading plan | 3,445 | $3.70 | $12.7K | 98,874 | 19 May 2026 |
| 15 May 2026 | Nash Marc, EVP Operations R&D & Service | Sale outside a trading plan | 1,582 | $3.70 | $5.9K | 38,393 | 19 May 2026 |
| 15 May 2026 | Brottem John L., General Counsel | Sale outside a trading plan | 2,638 | $3.70 | $9.8K | 30,277 | 19 May 2026 |
| 17 Feb 2026 | Brottem John L., General Counsel | Sale outside a trading plan | 2,842 | $3.35 | $9.5K | 32,935 | 19 Feb 2026 |
| 17 Feb 2026 | Trigg Leslie, Chair and CEO | Sale outside a trading plan | 3,361 | $3.35 | $11.3K | 102,342 | 19 Feb 2026 |
| 17 Feb 2026 | Nash Marc, EVP Operations R&D & Service | Sale outside a trading plan | 1,817 | $3.35 | $6.1K | 39,988 | 19 Feb 2026 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 14 Aug 2026 | Brottem John L., Officer | 2,562 | $11.5K | 17 Aug 2026 |
| 14 Aug 2026 | Trigg Leslie, Officer | 3,344 | $15.1K | 17 Aug 2026 |
| 14 Aug 2026 | Gaeta Renee, Officer | 4,422 | $19.9K | 17 Aug 2026 |
| 3 Jun 2026 | Gaeta Renee, Officer | 17,672 | $87.4K | 3 Jun 2026 |
| 15 May 2026 | Nash Marc, Officer | 1,582 | $5.9K | 15 May 2026 |
| 15 May 2026 | Brottem John L., Officer | 2,638 | $9.8K | 15 May 2026 |
| 15 May 2026 | Trigg Leslie, Officer | 3,445 | $12.7K | 15 May 2026 |
| 17 Feb 2026 | Brottem John L., Officer | 2,842 | $9.5K | 17 Feb 2026 |
| 17 Feb 2026 | Trigg Leslie, Officer | 3,361 | $11.3K | 17 Feb 2026 |
| 21 Jan 2026 | Nash Marc, Officer | 980 | $4.9K | 21 Jan 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 6 Oct 2026 | BML Investment Partners, L.P. | 13G amended | 14.7% | 2.8M |
| 12 Aug 2026 | AQR Capital Management, LLC | 13G | 5.39% | 999.0K |
| 12 Aug 2026 | BANK OF AMERICA CORP /DE/ | 13G amended | 3.5% | 666.6K |
| 29 Jul 2026 | BlackRock, Inc. | 13G amended | 2% | 365.6K |
| 18 May 2026 | BML Investment Partners, L.P. | 13G amended | 13.6% | 2.5M |
| 15 May 2026 | Alyeska Investment Group, L.P. | 13G amended | 0% | 0 |
| 15 May 2026 | Woodline Partners LP | 13G amended | 1.6% | 292.4K |
| 12 May 2026 | BML Investment Partners, L.P. | 13G amended | 11.8% | 2.2M |
| 27 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 17 Feb 2026 | Durable Capital Partners LP | 13G amended | 0% | 0 |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 932.6K | +17.64% | 3.79 |
| 30 Sep 2026 | 792.7K | -10.89% | 5.93 |
| 15 Sep 2026 | 889.6K | -1.34% | 6.18 |
| 31 Aug 2026 | 901.7K | -3.7% | 6.99 |
| 14 Aug 2026 | 936.3K | -18.04% | 5.97 |
| 31 Jul 2026 | 1.1M | -6.11% | 11.02 |
| 15 Jul 2026 | 1.2M | -18.52% | 6.28 |
| 30 Jun 2026 | 1.5M | -24.24% | 3.27 |
Funds that hold it
From each fund's latest Form 13F.
114 funds held it at 30 Jun 2026: 50 added and 26 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| FMR LLC | 2,742,887 | $11.8M | +1,214 |
| BML Capital Management, LLC | 2,519,701 | $10.9M | +617,500 |
| AQR Capital Management LLC | 998,961 | $4.3M | +190,676 |
| Perceptive Advisors LLC | 833,333 | $3.6M | 0 |
| Vanguard Capital Management LLC | 780,134 | $3.4M | +16,312 |
| Assenagon Asset Management S.A. | 678,876 | $2.9M | – |
| Bank of America Corp. | 665,847 | $2.9M | -283,550 |
| PFM Health Sciences, LP | 582,122 | $2.5M | -12,508 |
| Ensign Peak Advisors, Inc | 434,341 | $1.9M | -92,244 |
| BlackRock, Inc. | 418,211 | $1.8M | -845,008 |
Peers
Companies in the same industry.
- Medtronic plc (MDT): revenue $37.5B, market value $123.6B
- LivaNova plc (LIVN): revenue $1.5B, market value $4.3B
- Integer Holdings Corp. (ITGR): revenue $1.8B, market value $4.3B
- Axogen, Inc. (AXGN): revenue $266.9M, market value $2.9B
- TransMedics Group, Inc. (TMDX): revenue $668.5M, market value $2.3B
- Conmed Corp. (CNMD): revenue $1.4B, market value $1.3B
- Ceribell, Inc. (CBLL): revenue $102.0M, market value $1.0B
- CapsoVision, Inc. (CV): revenue $13.9M, market value $341.7M
- Electromed, Inc. (ELMD): revenue $73.8M, market value $225.0M
- Edap TMS SA (FOCL): revenue –, market value $157.6M